Laboratoires Pomega developq a patented Anti Inflammatory Drug.
Creation : June 2023
Employees : 5
Place : Archamps
Activity (biotech/medtech/healthtech) : Biotech
Who ?
Laboratoires Pomega developq a patented Anti Inflammatory Drug (Ω-344) made of pomegranate byproducts and containing active ingredients for prevention and treatment of osteoarthritis, the most common chronic degenerative joint disorder in elderly/obese dogs and cats across the world.
Current approved therapeutics for osteoarthritis in dogs are mainly linked to anti-inflammatory corticosteroids, NSAIDs and painkillers with potential gastrointestinal and cardiovascular toxicities. Ω-344 is a novel, safe, ethical and non-toxic therapy that retards disease progression by inhibiting cartilage breakdown at an earlier stage developed by skilled pharmacist under drug standards frame.
Why became a Lyonbiopole’s member ?
We wanted to join the cluster in order to be able to share our knowledge and also benefit from the experience of other SME, academic and institutional actors during future exchanges.
Soumya BOUGUEDOURA
CEO – Pomega